CorDx COVID-19 Ag Test

FEATURES AND BENEFITS:

Results in 10 minutes.
Extensively validated through strict EUA clinical study during time of Omicron prominence.
Evaluated againstBQ.1/ BQ.1.1 variant.
High sensitivity and specificity
Efficient sample processing solution tube design.
Built in tube holders on the kit box.
One manufacture site in China, two manufacture sites in the U.S.
15-month shelf life

Description

The CorDx COVID-19 Ag Test is a lateral flow immunoassay device intended for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus, delivering results in just 10 minutes.

This test is authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older, or adult collected anterior nasal (nares) swab samples from individuals aged two years or older. This test is authorized for individuals with symptoms of COVID-19 within the first 7 days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and for individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested at least three times over five days with at least 48 hours between tests.